The University of Cincinnati Sponsored Research Services Division was awarded an $817,296 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research on spreading depolarizations as a predictive biomarker of post-traumatic epilepsy from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The University of Cincinnati received a $243,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Characterization of Novel Perivascular Lesions Caused by Specific Deletion of TSC2 in Hematopoietic Cells." The award period is from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program supports biomedical research aimed at improving the...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,342,184.00 to the University of Cincinnati to conduct research on "STATHMIN POST-TRANSLATIONAL PROCESSING AS A MECHANISM OF CASTRATION RESISTANCE." The project aims to investigate this biological mechanism with the potential to yield new treatments for military-relevant medical conditions. The award has a performance...
The U.S. Department of the Army Medical Command awarded a $2,289,304 Project Grant on August 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) to The Medical College of Wisconsin, Inc. The grant funds research to improve in-hospital and post-discharge patient education for mild traumatic brain injury. A sub-award was issued to The Ohio State University to support this research initiative. The grant aims to transform healthcare for military service members and...
The U.S. Air Force awarded a $1,758,800 Cooperative Agreement to the University of Cincinnati on June 12, 2024 under the Air Force Defense Research Sciences Program (CFDA 12.800). The funding supports the development of "Nanomedicine Systems for Targeted Treatment of TBI Plus Hemorrhagic Shock." The University of Cincinnati was also issued a $1,607,200 sub-award under this Cooperative Agreement on November 21, 2024 to further this research. As a leading public research institution, the...
The Department of the Army Medical Command awarded a $413,400 Project Grant to Children's Home Healthcare of Cincinnati, OH through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2023 exploring the role of endoplasmic reticulum stress and systemic inflammation in blunt traumatic brain injury-induced optic nerve damage. The Military Medical Research and Development program supports basic, applied, and...
The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...
The Department of the Army Medical Command awarded a $197,342 Project Grant to the RU School of Osteopathic Medicine through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through August 2025 to investigate the effects of psychostimulants on cognitive flexibility and risk-based decision-making behavior following repetitive mild traumatic brain injury. The Military Medical Research and Development program supports basic,...
The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...